Skip to Main Content

Author Details

Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
1990
184
52
PMIDPaper TitleJournal TitlePublished Year
36394580Allogeneic stem cell transplantation in patients with a prior history of prostate cancer.Ann Hematol2023
37481462Racial and sex differences in tumor genomics in urothelial carcinoma.Urol Oncol2023
37609344Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations.bioRxiv2023
37084735Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.Cancer Cell2023
37150667Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.Clin Genitourin Cancer2023
37344281Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study.Clin Genitourin Cancer2023
36623239Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.JCO Precis Oncol2023
36621991Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.J Urol2023
36399432Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.Cancer Discov2023
36710203Neoadjuvant Therapy Prior to Prostatectomy: Is the Glass Half Full?Eur Urol2023
36710146A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.Clin Genitourin Cancer2023
36564459Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer.Prostate Cancer Prostatic Dis2023
35998004Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.Cancer Immunol Immunother2023
34843005A phase 1 study to assess the safety, pharmacokinetics, and anti-tumor activity of the androgen receptor n-terminal domain inhibitor epi-506 in patients with metastatic castration-resistant prostate cancer.Invest New Drugs2022
35476551Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase Inhibitors.JCO Precis Oncol2022
35438754Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical Trial.JAMA Netw Open2022
35834759<i>BRCA2</i> Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case Series.JCO Precis Oncol2022
35641377Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy.Urol Oncol2022
35778337Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.Clin Genitourin Cancer2022
36601043Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis.Eur Urol Open Sci2022
35929009Ordering and Interpreting Precision Oncology Studies for Adults With Advanced Solid Tumors: A Primer.Fed Pract2022
35928922Chemotherapy Utilization in Men with Advanced Penile Cancer.Urol Pract2022
36028450Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events.Urol Oncol2022
36155169Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.Clin Genitourin Cancer2022
34863587Inherited TP53 Variants and Risk of Prostate Cancer.Eur Urol2022
33151258Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference.JAMA Oncol2021
35387424A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy.Adv Radiat Oncol2021
33849963Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance.Clin Cancer Res2021
33542074Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies.Clin Cancer Res2021
33755225Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer.Prostate2021
33633154A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture.Sci Rep2021
33551249Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.Urol Oncol2021
34877933Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer.JCI Insight2021
34407973Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer.Clin Cancer Res2021
34516663Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.Prostate2021
34086042Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA.JAMA Oncol2021
34225789Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.Trials2021
33160889Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program.Clin Genitourin Cancer2021
31411968A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.Eur Urol Oncol2020
34258585Accelerating precision medicine in metastatic prostate cancer.Nat Cancer2020
34109262Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes.Bladder Cancer2020
31640893Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.Eur Urol2020
31924316Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study.Eur Urol2020
32886903Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies.J Natl Compr Canc Netw2020
32997692Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer.PLoS One2020
32908353The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration.Fed Pract2020
32897829Two Steps Forward and One Step Back for Precision in Prostate Cancer Treatment.J Clin Oncol2020
32478682Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.J Clin Invest2020
32201105Downstaging of Muscle-Invasive Bladder Cancer Using Neoadjuvant Gemcitabine and Cisplatin or Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as Single Regimens or as Switch Therapy Modalities.Clin Genitourin Cancer2020
32460015Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress.Cell Rep2020
  • 1 - 50 of 184

Recommended Authors

Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Career Start Year 2013
Number of shared co-authors 15
Alec Paschalis
The Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 11
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 43
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 25
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 11
Niven Mehra
Radboud university medical center
Career Start Year 2004
Number of shared co-authors 37
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 7
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 47
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 21
Mark C Markowski
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Career Start Year 2001
Number of shared co-authors 14
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 41
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 12
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 50
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 13
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 34
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 37
Michael A Carducci
Johns Hopkins School of Medicine
Career Start Year 1995
Number of shared co-authors 39
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 38
Edwin M Posadas
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 40
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 56
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 29
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 7
Urban Emmenegger
Odette Cancer Centre
Career Start Year 1991
Number of shared co-authors 13
Fred Saad
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 46
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 52
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 49
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 20
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 9
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 39
John Trachtenberg
University of Toronto, University Health Network
Career Start Year 1971
Number of shared co-authors 6

Collaborators

Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 76
Elahe A Mostaghel
University of Washington
Co-authored papers 41
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 36
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 35
Mary-Ellen Taplin
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Co-authored papers 25
Daniel W Lin
Co-authored papers 25
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 24
Lawrence D True
University of Washington School of Medicine
Co-authored papers 24
Jonathan L Wright
University of Washington Medical Center
Co-authored papers 21
Ilsa Coleman
Fred Hutchinson Cancer Center
Co-authored papers 20
Robert L Vessella
University of Washington
Co-authored papers 18
Steven P Balk
Beth Israel Deaconess Medical Center and Harvard Medical School
Co-authored papers 17
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 16
Colm Morrissey
Co-authored papers 15
Stephen R Plymate
University of Washington
Co-authored papers 14
Eva Corey
University of Washington School of Medicine
Co-authored papers 14
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 12
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 11
Celestia S Higano
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 11
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 10
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Rosina T Lis
National Cancer Institute
Co-authored papers 9
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 9
Alvin M Matsumoto
Co-authored papers 9
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 8
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Mark A Rubin
University of Bern
Co-authored papers 8
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
John L Gore
University of Washington School of Medicine
Co-authored papers 7
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers 7
Release 1.2